SUNITINIB EG 25 mg, gélule — plaquette(s) aluminium OPA : polyamide orienté PVC de 28 gélule(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930175033 -
CIP7
3017503 -
CIS
67016410
What the source publishes
- Holder
- EG LABO - LABORATOIRES EUROGENERICS
- Active ingredients
- SUNITINIB
- Form
- gélule
- Package
- plaquette(s) aluminium OPA : polyamide orienté PVC de 28 gélule(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2019-03-15
- Prescription
- Prescription or restricted
Names this record is found by
- SUNITINIB EG 25 mg, gélule — plaquette(s) aluminium OPA : polyamide orienté PVC de 28 gélule(s)
- SUNITINIB EG 25 mg, gélule
- SUNITINIB
Complete source data
{
"cis": "67016410",
"cip7": "3017503",
"form": "gélule",
"name": "SUNITINIB EG 25 mg, gélule — plaquette(s) aluminium OPA : polyamide orienté PVC de 28 gélule(s)",
"cip13": "3400930175033",
"holder": "EG LABO - LABORATOIRES EUROGENERICS",
"routes": [
"orale"
],
"holders": [
"EG LABO - LABORATOIRES EUROGENERICS"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "929.64",
"authorisedOn": "2019-03-15",
"compositions": [
{
"name": "SUNITINIB",
"nature": "SA",
"strength": "25 mg",
"linkageNumber": "1",
"substanceCode": "29335",
"dosageReference": "une gélule",
"pharmaceuticalElement": "gélule"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "928.62",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "SUNITINIB EG 25 mg, gélule",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) aluminium OPA : polyamide orienté PVC de 28 gélule(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100 %"
],
"marketingDeclaredOn": "2022-01-27",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"SUNITINIB"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930175033"